Novartis strengthens antiinflammatory drugs portfolio with IFM Tre buy

Novartis strengthens anti-inflammatory drugs portfolio with IFM Tre buy

07:45 EDT 1 Apr 2019 | PharmaTimes

The Swiss company will pay $310 million in upfront payments.

Original Article: Novartis strengthens anti-inflammatory drugs portfolio with IFM Tre buy

More From BioPortfolio on "Novartis strengthens anti-inflammatory drugs portfolio with IFM Tre buy"